Regulatory Filings • Apr 3, 2020
Regulatory Filings
Open in ViewerOpens in native device viewer
Disclosure 381994
Optomed Plc Stock Exchange Release 3 April 2020 at 9.00, Helsinki Optomed postpones its Annual General Meeting Optomed postpones its Annual General Meeting due to the COVID-19 pandemic. Previously, the Company has informed that the meeting will be held on 28 April 2020. The new date of the Annual General Meeting will be disclosed in due course. The meeting will be arranged in accordance with all the regulatory guidelines and ensuring the health and safety of shareholders and Optomed personnel. Optomed will convene the Annual General Meeting at a later stage. Optomed Plc Further enquiries Sakari Knuutti, CLO, Optomed Plc, [email protected] ([email protected]) Optomed in Brief Optomed is a Finnish medical technology company and one of the leading providers of handheld fundus cameras. Optomed combines handheld screening devices with software and artificial intelligence with the aim to transform the diagnostic process of blinding eye-diseases such as rapidly increasing diabetic retinopathy. In its business Optomed focuses on eye-screening devices and software solutions related R&D in Finland and sales through different channels in over 60 countries. The company has an extensive portfolio of 55 international patents protecting the technology. In 2019, Optomed’s revenue reached EUR 15 million and 2018 pro forma revenue amounted to EUR 14.5 million. At the end of 2019, Optomed employed 108 professionals.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.